Comparative proteome analysis of thalamus in MK-801-treated rats

Proteomics

Volumn 4, Issue 3, 2004, Pages 819-825

  Paulson, Linda ^a,d   Martin, Peter ^b   Nilsson, Carol L ^a   Ljung, Elisabeth ^b   Westman Brinkmalm, Ann ^a   Blennow, Kaj ^a   Davidsson, Pia ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Carlsson Research AB   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Mass spectrometry; Rat; Thalamus; Two dimensional gel electrophoresis

Indexed keywords

DIHYDROLIPOAMIDE ACETYLTRANSFERASE; DIZOCILPINE; PROTEOME;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; COMPLEX FORMATION; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; RAT; SCHIZOPHRENIA; THALAMUS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; DIZOCILPINE MALEATE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EXCITATORY AMINO ACID ANTAGONISTS; MASS SPECTROMETRY; N-METHYLASPARTATE; PROTEOME; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THALAMUS;

ANIMALIA;

EID: 1542406235     PISSN: 16159853     EISSN: None     Source Type: Journal    
DOI: 10.1002/pmic.200300622     Document Type: Article

References (39)

1. Brown, S., Br. J. Psychiatry 1997, 502-508.
2. Andreasen, N. C., Flashman, L., Flaum, M., Arndt, S. et al., Jama 1994, 22, 1763-1769.
3. Blennow, K., Bogdanovic, N., Gottfries, C. G., Davidsson, P., J. Mol. Neurosci. 1999, 1-2, 101-109.
4. Eastwood, S. L., Burnet, P. W., Harrison, P. J., Neuroscience 1995, 2, 309-319.
5. Sokolov, B. P., Tcherepanov, A. A., Haroutunian, V., Davis, K. L., Biol. Psychiatry 2000, 3, 184-196.
6. Blennow, K., Davidsson, P., Gottfries, C. G., Ekman, R. et al., Lancet 1996, 9028, 692-693.
7. Davidsson, P., Gottfries, J., Bogdanovic, N., Ekman, R. et al., Schizophr. Res. 1999, 1, 23-29.
8. Javitt, D. C., Zukin, S. R., Am. J. Psychiatry 1991, 10, 1301-1308.
9. Javitt, D. C., Zukin, S. P., Schizophrenia Res. Progr. 1991, 12-19.
10. Tamminga, C. A., Holcomb, H. H., Gao, X. M., Lahti, A. C., Int. Clin. Psychopharmacol. 1995, 29-37.
11. Ellison, G., Brain Res. Brain Res. Rev. 1995, 2, 250-267.
12. Carlsson, M., Carlsson, A., Trends Neurosci. 1990, 7, 272-276.
13. Paulson, L., Martin, P., Persson, A., Nilsson, C. L. et al., J. Neurosci. Res. 2003, 4, 526-533.
14. Carlsson, A., Lindqvist, M., J. Pharm. Pharmacol. 1973, 6, 437-440.
15. Davidsson, P., Westman-Brinkmalm, A., Nilsson, C. L., Lindbjer, M. et al., Neuroreport 2002, 5, 611-615.
16. Hiramatsu, M., Cho, A. K., Nabeshima, T., Eur. J. Pharmacol. 1989, 3, 359-366.
17. Selemon, L. D., Schizophr. Bull. 2001, 3, 349-377.
18. Johnston-Wilson, N. L., Sims, C. D., Hofmann, J. P., Anderson, L. et al., Mol. Psychiatry 2000, 2, 142-149.
19. Middleton, F. A., Mirnics, K., Pierri, J. N., Lewis, D. A. et al., J. Neurosci. 2002, 7, 2718-2729.
20. Schwarz, M. J., Riedel, M., Gruber, R., Ackenheil, M. et al., Am. J. Psychiatry 1999, 7, 1103-1104.
21. Mazeh, D., Sirota, P., Patya, M., Novogrodsky, A., J. Neuroimmunol. 1998, 2, 218-222.
22. Yao, J. K., Reddy, R., van Kammen, D. P., Psychiatry Res. 2000, 2-3, 137-151.
23. Sharp, F. R., Jasper, P., Hall, J., Noble, L. et al., Ann. Neurol. 1991, 6, 801-809.
24. Kopecek, P., Altmannova, K., Weigl, E., Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2001, 2, 39-47.
25. Matuda, S., Nakano, K., Ohta, S., Shimura, M. et al., Biochim. Biophys. Acta 1992, 1, 114-118.
26. Paletzki, R. F., Neuroscience 2002, 1, 15-26.
27. Sakimura, K., Kushiya, E., Obinata, M., Odani, S. et al., Proc. Natl. Acad. Sci. USA 1985, 21, 7453-7457.
28. Bajo, M., Fruehauf, J., Kim, S. H., Fountoulakis, M. et al., Proteomics 2002, 11, 1539-1546.
29. Evans, J., Sumners, C., Moore, J., Huentelman, M. J. et al., J. Neurophysiol. 2002, 2, 1076-1085.
30. Mukai, T., Yatsuki, H., Masuko, S., Arai, Y. et al., Biochem. Biophys. Res. Commun. 1991, 2, 1035-1042.
31. Marchbanks, R. M., Mulcrone, J., Whatley, S. A., Br. J. Psychiatry 1995, 3, 293-298.
32. Maurer, I., Zierz, S., Moller, H., Schizophr. Res. 2001, 1, 125-136.
33. Whatley, S. A., Curti, D., Marchbanks, R. M., Neurochem. Res. 1996, 9, 995-1004.
34. Whatley, S. A., Curti, D., Das Gupta, F., Ferrier, I. N. et al., Mol. Psychiatry 1998, 3, 227-237.
35. Prince, J. A., Blennow, K., Gottfries, C. G., Karlsson, I. et al., Neuropsychopharmacology 1999, 3, 372-379.
36. Lubec, G., Nonaka, M., Krapfenbauer, K., Gratzer, M. et al., J. Neural Transm. Suppl. 1999, 161-177.
37. Castegna, A., Aksenov, M., Thongboonkerd, V., Klein, J. B. et al., J. Neurochem. 2002, 6, 1524-1532.
38. Op den Velde, W., Stam, F. C., J. Am. Geriatr. Soc. 1976, 1, 12-16.
39. Kumar, S., Ou, S. W., Rathi, M., N. Engl. J. Med. 1979, 23, 1332-1333.